Aaron Cumpston

1.1k total citations
55 papers, 722 citations indexed

About

Aaron Cumpston is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, Aaron Cumpston has authored 55 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 16 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in Aaron Cumpston's work include Hematopoietic Stem Cell Transplantation (23 papers), Acute Myeloid Leukemia Research (11 papers) and Acute Lymphoblastic Leukemia research (8 papers). Aaron Cumpston is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Acute Myeloid Leukemia Research (11 papers) and Acute Lymphoblastic Leukemia research (8 papers). Aaron Cumpston collaborates with scholars based in United States, Spain and Canada. Aaron Cumpston's co-authors include Michael Craig, Mehdi Hamadani, Abraham S. Kanate, Sijin Wen, Douglas Slain, Katherine E. Watkins, Michael Sweet, Gerry Hobbs, Farrukh T. Awan and Arif R Sarwari and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aaron Cumpston

51 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Cumpston United States 17 295 243 199 189 64 55 722
LeAnne Kennedy United States 12 278 0.9× 450 1.9× 189 0.9× 264 1.4× 206 3.2× 33 981
Jack W. Hsu United States 18 518 1.8× 159 0.7× 264 1.3× 86 0.5× 88 1.4× 52 979
Nurith Strauss Israel 14 149 0.5× 346 1.4× 178 0.9× 89 0.5× 65 1.0× 21 779
Victor M. Aquino United States 16 121 0.4× 218 0.9× 417 2.1× 97 0.5× 65 1.0× 36 840
Hirozumi Sano Japan 12 127 0.4× 107 0.4× 148 0.7× 107 0.6× 25 0.4× 55 482
Saloua Ladeb Tunisia 15 230 0.8× 95 0.4× 145 0.7× 68 0.4× 34 0.5× 55 688
Maurizio Buelli Italy 7 154 0.5× 132 0.5× 440 2.2× 67 0.4× 53 0.8× 13 599
W. N. Patton New Zealand 14 127 0.4× 159 0.7× 166 0.8× 70 0.4× 99 1.5× 32 675
Federica Giannotti Switzerland 15 222 0.8× 189 0.8× 122 0.6× 121 0.6× 25 0.4× 47 632
Saveria Capria Italy 19 543 1.8× 278 1.1× 442 2.2× 206 1.1× 163 2.5× 70 1.3k

Countries citing papers authored by Aaron Cumpston

Since Specialization
Citations

This map shows the geographic impact of Aaron Cumpston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Cumpston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Cumpston more than expected).

Fields of papers citing papers by Aaron Cumpston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Cumpston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Cumpston. The network helps show where Aaron Cumpston may publish in the future.

Co-authorship network of co-authors of Aaron Cumpston

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Cumpston. A scholar is included among the top collaborators of Aaron Cumpston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Cumpston. Aaron Cumpston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ross, Kelly G., et al.. (2022). Evaluation of the Pharmacokinetic Interaction Between Letermovir and Tacrolimus in Allogeneic Hematopoietic Cell Transplantation Recipients. Transplantation and Cellular Therapy. 28(7). 371.e1–371.e4. 9 indexed citations
2.
Kanate, Abraham S., Anikó Szabó, Renju Raj, et al.. (2019). Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 25(7). 1456–1464. 14 indexed citations
3.
McCune, Jeannine S., Tao Wang, Mahmoud Aljurf, et al.. (2019). Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning. Biology of Blood and Marrow Transplantation. 25(7). 1424–1431. 16 indexed citations
4.
Shah, Nilay, Aaron Cumpston, Sijin Wen, et al.. (2019). Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients. SHILAP Revista de lepidopterología. 1(2). 101–104. 2 indexed citations
5.
Kanate, Abraham S., Parameswaran Hari, Marcelo C. Pasquini, et al.. (2017). Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation. Biology of Blood and Marrow Transplantation. 23(8). 1295–1302. 10 indexed citations
6.
Kanate, Abraham S., et al.. (2017). Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia. Advances in Hematology. 2017. 1–4. 5 indexed citations
7.
Dhakal, Binod, Timothy S. Fenske, Daniel Eastwood, et al.. (2016). Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 22(10). 1773–1780. 3 indexed citations
8.
Shah, Nilay, Sijin Wen, Michael Craig, et al.. (2016). Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL). Bone Marrow Transplantation. 52(2). 321–322. 2 indexed citations
9.
Cumpston, Aaron, Sijin Wen, Katherine E. Watkins, et al.. (2015). Hematopoietic progenitor cell mobilization with “just-in-time” plerixafor approach is a cost-effective alternative to routine plerixafor use. Cytotherapy. 17(12). 1785–1792. 27 indexed citations
10.
11.
Kanate, Abraham S., Katherine E. Watkins, Aaron Cumpston, Michael Craig, & Mehdi Hamadani. (2013). Salvage Bone Marrow Harvest in Patients Failing Plerixafor-Based Stem Cell Mobilization Attempt: Feasibility and Autologous Transplantation Outcomes. Biology of Blood and Marrow Transplantation. 19(7). 1133–1135. 4 indexed citations
12.
Awan, Farrukh T., Samith T. Kochuparambil, Aaron Cumpston, et al.. (2013). Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies. Bone Marrow Transplantation. 48(10). 1279–1284. 41 indexed citations
13.
14.
Awan, Farrukh T., Samith T. Kochuparambil, David L. DeRemer, et al.. (2012). Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization. Journal of Oncology. 2012. 1–5. 11 indexed citations
15.
Hamadani, Mehdi, Samith T. Kochuparambil, Aaron Cumpston, et al.. (2012). Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies. Biology of Blood and Marrow Transplantation. 18(7). 1128–1135. 55 indexed citations
16.
Slain, Douglas, et al.. (2012). Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis. International Journal of Antimicrobial Agents. 40(6). 557–561. 17 indexed citations
17.
Kanate, Abraham S., Michael Craig, Aaron Cumpston, et al.. (2011). Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation. Hematology/Oncology and Stem Cell Therapy. 4(4). 149–156. 4 indexed citations
18.
19.
Slain, Douglas, et al.. (2011). A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis. International Journal of Antimicrobial Agents. 37(3). 266–269. 51 indexed citations
20.
Craig, Michael, Aaron Cumpston, Gerry Hobbs, et al.. (2007). The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit. Bone Marrow Transplantation. 39(8). 477–482. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LeAnne Kennedy Breakdown of academic impact, for papers by Jack W. Hsu Breakdown of academic impact, for papers by Nurith Strauss Breakdown of academic impact, for papers by Victor M. Aquino Breakdown of academic impact, for papers by Hirozumi Sano Breakdown of academic impact, for papers by Saloua Ladeb Breakdown of academic impact, for papers by Maurizio Buelli Breakdown of academic impact, for papers by W. N. Patton Breakdown of academic impact, for papers by Federica Giannotti Breakdown of academic impact, for papers by Saveria Capria
Rankless by CCL
2026